Effects of Personalized Training at Home Combining Endurance and Resistance in Patients Suffering From Marfan Syndrome (MARF'HOME)
Primary Purpose
Marfan Syndrome
Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Endurance training
Muscle building training
Sponsored by
About this trial
This is an interventional supportive care trial for Marfan Syndrome focused on measuring Physical training
Eligibility Criteria
Inclusion Criteria:
- patient with Marfan syndrome and followed up at Bichat Claude Bernard hospital, Paris. Marfan syndrome should be diagnosed according to the Ghent nosology revised in 2010
- Patient taking protective treatment for the aorta (beta blocker, calcium channel blocker, ACE inhibitor, angiotensin II receptor antagonist).
- Valid patient, able to return to consultation and carry out functional assessments and personalized physical training at home.
- Patients operated prophylactically on the ascending aorta may be included at a distance > 6 months from their surgery.
Exclusion Criteria:
- Myocardial pathology other than Marfan syndrome.
- Thoracic aorta dissection.
- Aortic diameter > 45 millimeters.
- Uncontrolled high blood pressure at rest (systolic blood pressure > 140 Millimeter of mercury and diastolic blood pressure > 90 Millimeter of mercury)
- Increase in systolic blood pressure > 160 Millimeter of mercury during exercise.
- Pregnancy at the time of the study
Sites / Locations
- Groupe Hospitalier Bichat - Claude Bernard
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
No Intervention
Experimental
Experimental
Experimental
Arm Label
Group 1
Group 2
Group 3
Group 4
Arm Description
No physical training
Endurance training
Muscle building training
Training combining endurance + muscle building
Outcomes
Primary Outcome Measures
Quality of life assessment: questionnaire
Assessed with Medical Outcome Study Short Form 36 questionnaire, a scale scored on a 0 to 100 range so that the lowest is the worth condition and highest is the best condition.
Secondary Outcome Measures
Pain assessment: Fibromyalgia Rapid Screening Tool
Assessed with Fibromyalgia Rapid Screening Tool
Self-perception assessment
Assessed with Physical Self Inventory questionnaire, a scale scoring 25 items rated on a 6-point scale ranging from 1 (Not at all) to 6 (Entirely) and assessing 6 dimensions (global self-worth (10-50), physical self-worth (10-50), physical condition (10-50), sport competence (10-40), physical attractiveness (10-30), and physical strength (10-30)) of the physical self-conception.
Aortic diameter
Evolution of the aortic diameter (in millimeter) in echocardiography, safety cardiovascular parameters
Blood pressure
Evolution of the systolic and diastolic blood pressures (in Millimeter of mercury) during exercise, monitoring of physiological parameters
Heart rate
Evolution of heart rate (Beats per minute) during exercise, monitoring of physiological parameters
oxygen consumption
Evolution of oxygen consumption (in liter) during exercise, monitoring of physiological parameters
Maximal voluntary contraction
Evolution of maximal voluntary contraction (in Newtons) during exercise, monitoring of physiological parameters
Left Ventricular Ejection Fraction (LVEF)
Evolution of Left Ventricular Ejection Fraction (in percentage) at rest, monitoring of cardiovascular parameters.
Global longitudinal strain (GLS)
Evolution of GLS (in percentage) at rest, monitoring of cardiovascular parameters
Full Information
NCT ID
NCT04553094
First Posted
September 11, 2020
Last Updated
September 30, 2022
Sponsor
French Cardiology Society
1. Study Identification
Unique Protocol Identification Number
NCT04553094
Brief Title
Effects of Personalized Training at Home Combining Endurance and Resistance in Patients Suffering From Marfan Syndrome
Acronym
MARF'HOME
Official Title
Evaluation of the Effects of Personalized Training at Home Combining Endurance and Resistance in Patients Suffering From Marfan Syndrome
Study Type
Interventional
2. Study Status
Record Verification Date
September 2022
Overall Recruitment Status
Completed
Study Start Date
January 4, 2021 (Actual)
Primary Completion Date
September 30, 2022 (Actual)
Study Completion Date
September 30, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
French Cardiology Society
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Marfan syndrome (MS) is an autosomal dominant genetic disorder caused by a mutation in the fibrillin-1 gene (FBN1) encoding the protein fibrillin-1. Fibrillin is the main component of microfibrils, elements found in all of the body's tissues, and this pathology is characterized by the multitude of its clinical manifestations. These patients may develop aneurysms in the aortic root and one of the main factors of morbidity in patients with MS is aortic dissection. Prevention mainly involves preventive aortic surgery. However, the repercussions are global and can affect the functioning of other tissues such as skeletal muscle tissue, bone tissue, lung tissue and the eyes. The association of skeletal (scoliosis, hyperlaxity), muscular and ocular disorders is clearly associated with an impairment in the quality of life. These disorders are associated with pain and disability which affect professional activity, leisure and family life.
Physical activity could represent a relevant alternative for these patients. A recent animal study suggests that moderate training is beneficial.
Detailed Description
The main objective is to show that the quality of life of patients with Marfan syndrome can be improved by personalized training at home. The goal is to be able to offer new non-drug management based on physical activity to these patients.
Improved quality of life; Improvement of muscle strength by a muscle strengthening protocol; Improvement of cardiovascular function parameters. Regular coaching throughout the study.
/ Assessment of muscular capacities
/ Assessment of cardiovascular and respiratory capacities
/ Response to psychometric questionnaires
/ Participation in a training circuit (training protocol)
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Marfan Syndrome
Keywords
Physical training
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
3 groups of physical training intervention compared with control group
Masking
None (Open Label)
Allocation
Randomized
Enrollment
72 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Group 1
Arm Type
No Intervention
Arm Description
No physical training
Arm Title
Group 2
Arm Type
Experimental
Arm Description
Endurance training
Arm Title
Group 3
Arm Type
Experimental
Arm Description
Muscle building training
Arm Title
Group 4
Arm Type
Experimental
Arm Description
Training combining endurance + muscle building
Intervention Type
Other
Intervention Name(s)
Endurance training
Intervention Description
Aerobic circuit training
Intervention Type
Other
Intervention Name(s)
Muscle building training
Intervention Description
Muscle strengthening circuit training
Primary Outcome Measure Information:
Title
Quality of life assessment: questionnaire
Description
Assessed with Medical Outcome Study Short Form 36 questionnaire, a scale scored on a 0 to 100 range so that the lowest is the worth condition and highest is the best condition.
Time Frame
3 months
Secondary Outcome Measure Information:
Title
Pain assessment: Fibromyalgia Rapid Screening Tool
Description
Assessed with Fibromyalgia Rapid Screening Tool
Time Frame
3 months
Title
Self-perception assessment
Description
Assessed with Physical Self Inventory questionnaire, a scale scoring 25 items rated on a 6-point scale ranging from 1 (Not at all) to 6 (Entirely) and assessing 6 dimensions (global self-worth (10-50), physical self-worth (10-50), physical condition (10-50), sport competence (10-40), physical attractiveness (10-30), and physical strength (10-30)) of the physical self-conception.
Time Frame
3 months
Title
Aortic diameter
Description
Evolution of the aortic diameter (in millimeter) in echocardiography, safety cardiovascular parameters
Time Frame
3 months
Title
Blood pressure
Description
Evolution of the systolic and diastolic blood pressures (in Millimeter of mercury) during exercise, monitoring of physiological parameters
Time Frame
3 months
Title
Heart rate
Description
Evolution of heart rate (Beats per minute) during exercise, monitoring of physiological parameters
Time Frame
3 months
Title
oxygen consumption
Description
Evolution of oxygen consumption (in liter) during exercise, monitoring of physiological parameters
Time Frame
3 months
Title
Maximal voluntary contraction
Description
Evolution of maximal voluntary contraction (in Newtons) during exercise, monitoring of physiological parameters
Time Frame
3 months
Title
Left Ventricular Ejection Fraction (LVEF)
Description
Evolution of Left Ventricular Ejection Fraction (in percentage) at rest, monitoring of cardiovascular parameters.
Time Frame
3 months
Title
Global longitudinal strain (GLS)
Description
Evolution of GLS (in percentage) at rest, monitoring of cardiovascular parameters
Time Frame
3 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
patient with Marfan syndrome and followed up at Bichat Claude Bernard hospital, Paris. Marfan syndrome should be diagnosed according to the Ghent nosology revised in 2010
Patient taking protective treatment for the aorta (beta blocker, calcium channel blocker, ACE inhibitor, angiotensin II receptor antagonist).
Valid patient, able to return to consultation and carry out functional assessments and personalized physical training at home.
Patients operated prophylactically on the ascending aorta may be included at a distance > 6 months from their surgery.
Exclusion Criteria:
Myocardial pathology other than Marfan syndrome.
Thoracic aorta dissection.
Aortic diameter > 45 millimeters.
Uncontrolled high blood pressure at rest (systolic blood pressure > 140 Millimeter of mercury and diastolic blood pressure > 90 Millimeter of mercury)
Increase in systolic blood pressure > 160 Millimeter of mercury during exercise.
Pregnancy at the time of the study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Guillaume JONDEAU, MD
Organizational Affiliation
Groupe Hospitalier Bichat - Claude Bernard
Official's Role
Principal Investigator
Facility Information:
Facility Name
Groupe Hospitalier Bichat - Claude Bernard
City
Paris
ZIP/Postal Code
75018
Country
France
12. IPD Sharing Statement
Learn more about this trial
Effects of Personalized Training at Home Combining Endurance and Resistance in Patients Suffering From Marfan Syndrome
We'll reach out to this number within 24 hrs